Activation of a Ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation

Virology

Volumn 240, Issue 1, 1998, Pages 93-99

  Roberts, M Luisa ^a   Cooper, Neil R ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; RAS PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL TRANSFORMATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; RAT;

EID: 0032484473     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8901     Document Type: Article

References (48)

1. Alfieri C., Birkenbach M., Kieff E. Early events in Epstein-Barr virus infection of human B lymphocytes. Virology. 181:1991;595-608.
2. Allday M. J., Crawford D. H., Griffin B. E. Epstein-Barr virus latent gene expression during the initiation of B cell immortalization. J. Gen. Virol. 70:1989;1755-1764.
3. Arvanitakis L., Yaseen N., Sharma S. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-β1-mediated growth inhibition in EBV-positive B cells. J. Immunol. 155:1995;1047-1056.
4. Baichwal V. R., Sugden B. Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene. 2:1988;461-467.
5. Barbacid M. ras. Ann. Rev. Biochem. 56:1987;779-827.
6. Birkenbach M., Liebowitz D., Wang F., Sample J., Kieff E. Epstein-Barr virus latent infection membrane protein induces vimentin expression in human B-cell lines. J. Virol. 63:1989;4079-4084.
7. Chen W., Cooper N. R. Epstein-Barr virus nuclear antigen 2 and latent membrane protein independently transactivate p53 through induction of NF-κB activity. J. Virol. 70:1996;4849-4853.
8. Cowley S., Paterson H., Kemp P., Marshall C. J. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell. 77:1994;841-852.
9. Dawson C. W., Rickinson A. B., Young L. S. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature. 344:1990;777-780.
10. Fahraeus R., Li Fu H., Ernberg I., Finke J., Rowe M., Klein G., Falk K., Nilsson E., Yadav M., Busson P., Tursz T., Kallin B. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int. J. Cancer. 42:1988;329-338.
11. Fahraeus R., Rymo L., Rhim J. S., Klein G. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature. 345:1990;447-449.
12. Fairbairn L. J., Stewart J. P., Hampson I. N., Arrand J. R., Dexter T. M. Expression of Epstein-Barr virus latent membrane protein influences self renewal and differentiation in a multipotential murine haemopoietic stem cell line. J. Gen. Virol. 1993;247-254.
13. Feig L. A., Cooper G. M. Inhibition of NIH 3T3 cell proliferation by a mutantras. Mol. Cell. Biol. 8:1988;3235-3243.
14. TCFfos. Nature. 358:1992;414-417.
15. Gregory C. D., Dive C., Henderson S., Smith C. A., Williams G. T., Gordon J., Rickinson A. B. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature. 349:1991;612-614.
16. Hammarskjöld M.-L., Simurda M. C. Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-κB activity. J. Virol. 66:1992;6496-6501.
17. Hammerschmidt W., Sugden B. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature. 340:1989;393-397.
18. Henderson S., Rowe M., Gregory C., Croom-Carter D., Wang F., Longnecker R., Kieff E., Rickinson A. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell. 65:1991;1107-1115.
19. Ho M., Miller G., Atchison R. W., Breinig M. K., Dummer J. S., Andiman W., Starzl T. E., Eastman R., Griffith B. P., Hardesty R. L., Bahnson H. T., Hakala T. R., Rosenthal J. T. Epstein-Barr virus infections and DNA hybridization studies in posttransplant lymphoma and lymphoproliferative lesions: The role of primary infection. J. Infect. Dis. 152:1985;876-886.
20. Huen D. S., Henderson S. A., Croom-Carter D., Rowe M. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-κB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene. 10:1995;549-560.
21. Johnson N. L., Gardner A. M., Diener K. M., Lange-Carter C. A., Gleavy J., Jarpe M. B., Minden A., Karin M., Zon L. I., Johnson G. L. Signal transduction pathways regulated by mitogen-activated extracellular response kinase kinase kinase induce cell death. J. Biol. Chem. 271:1996;3229-3237.
22. Karp J. E., Broder S. Acquired immunodeficiency syndrome and non-Hodgkin's lymphomas. Cancer Res. 51:1991;4743-4756.
23. Kaye K. M., Izumi K. M., Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA. 90:1993;9150-9154.
24. Klein G. Viral latency and transformation: The strategy of Epstein-Barr virus. Cell. 58:1989;5-8.
25. Kolch W., Heldecker G., Kochs G., Hummel R., Vahidl H., Mischak H., Finkenzeller G., Marme D., Rapp U. Protein kinase Cα activates RAF-1 by direct phosphorylation. Nature. 364:1993;249-252.
26. Laherty C. D., Hu H. M., Opipari A. W., Wang F., Dixit V. M. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kB. J. Biol. Chem. 267:1992;24157-24160.
27. Liebowitz D., Wang D., Kieff E. Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus. J. Virol. 58:1986;233-237.
28. Luxembourg A. T., Cooper N. R. T cell dependent B cell activating properties of antibody-coated small latex beads: A new model for B cell activation. J. Immunol. 153:1994;604-614.
29. Mann K. P., Staunton D., Thorley-Lawson D. A. Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells. J. Virol. 55:1985;710-720.
30. Mannick J. B., Cohen J. I., Birkenbach M., Marchini A., Kieff E. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J. Virol. 65:1991;6826-6837.
31. Moorthy R. K., Thorley-Lawson D. A. All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of Rat-1 fibroblasts. J. Virol. 67:1993;1638-1646.
32. 2+. J. Virol. 68 No. 3:1994;1697-1705.
33. Mosialos G., Birkenbach M., Yalamanchili R., VanArsdale T., Ware C., Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell. 80:1995;389-399.
34. Mulcahy L. S., Smith M. R., Stacey D. W. Requirement forras. Nature. 313:1985;241-243.
35. Mulligan R. C., Berg P. Selection for animal cells that express theEscherichia coli. Proc. Natl. Acad. Sci. USA. 78:1981;2072-2076.
36. Nakagomi H., Dolcetti R., Bejarano M. T., Pisa P., Kiessling R., Masucci M. G. The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines. Int. J. Cancer. 57:1994;240-244.
37. mapkmapk. Proc. Natl. Acad. Sci. USA. 90:1993;8319-8323.
38. Pallesen G., Hamilton-Dutoit S. J., Rowe M., Young L. S. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet. 337:1991;320-322.
39. Peng M., Lundgren E. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis. Oncogene. 7:1992;1775-1782.
40. Pulverer B. J., Kyriakis J. M., Avruch J., Nikolakaki E., Woodgett J. R. Phosphorylation of c-jun. Nature. 353:1991.
41. Repko E. M., Maltese W. A. Post-translational isoprenylation of cellular proteins is altered in response to mevalonate availability. J. Biol. Chem. 264:1989;9945-9952.
42. Rickinson A. B., Kieff E. Fields Virology. 1996;Lippincott-Raven, Philadelphia. p. 2397-2446.
43. 01. EMBO J. 13:1994;3321-3328.
44. Stacey D. W., Feig L. A., Gibbs J. B. Dominant inhibitoryrasras. Mol. Cell. Biol. 11:1991;4053-4064.
45. Su I.-J., Hsieh H.-C., Lin K.-H., Uen W.-C., Kao C.-L., Chen C.-J., Cheng A.-L., Kadin M. E., Chen J.-Y. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: A clinicopathologic and molecular analysis. Blood. 77:1991;799-808.
46. Tomkinson B., Robertson E., Kieff E. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J. Virol. 67:1993;2014-2025.
47. Troppmair J., Bruder J. T., Munoz H., Lloyd P. A., Kyriakis J., Banerjee P., Avruch J., Rapp U. R. Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-O. J. Biol. Chem. 269:1994;7030-7035.
48. Wang D., Liebowitz D., Kieff E. An Epstein-Barr virus membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell. 43:1985;831-840.